These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6280564)

  • 1. Recent advances in the molecular mechanisms of human and animal models of myasthenia gravis.
    Albuquerque EX; Warnick JE; Mayer RF; Eldefrawi AT; Eldefrawi ME
    Ann N Y Acad Sci; 1981; 377():496-518. PubMed ID: 6280564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired slow-channel syndrome: a form of myasthenia gravis with prolonged open time of the acetylcholine receptor channel.
    Wintzen AR; Plomp JJ; Molenaar PC; van Dijk JG; van Kempen GT; Vos RM; Wokke JH; Vincent A
    Ann Neurol; 1998 Oct; 44(4):657-64. PubMed ID: 9778265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis animal model: quantitative analysis of the efficiency of pre- and postjunctional regions of intercostal muscles in rabbits immunized with Torpedo acetylcholine receptor.
    Albuquerque EX; Eldefrawi AT; Oliveira AC; Copio DS; Eldefrawi ME
    Exp Neurol; 1979 Oct; 66(1):109-22. PubMed ID: 225189
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies modify acetylcholine-induced ionic channel properties in cultured chick myoballs.
    Goldberg G; Mochly-Rosen D; Fuchs S; Lass Y
    J Membr Biol; 1983; 76(2):123-8. PubMed ID: 6315946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital myasthenic syndromes: II. Syndrome attributed to abnormal interaction of acetylcholine with its receptor.
    Uchitel O; Engel AG; Walls TJ; Nagel A; Atassi MZ; Bril V
    Muscle Nerve; 1993 Dec; 16(12):1293-301. PubMed ID: 8232384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases.
    Vincent A; Cull-Candy SG; Newsom-Davis J; Trautmann A; Molenaar PC; Polak RL
    Muscle Nerve; 1981; 4(4):306-18. PubMed ID: 7254233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
    Elias SB; Appel SH
    Ann Neurol; 1978 Sep; 4(3):250-2. PubMed ID: 718136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intercostal muscle biopsy studies in myasthenia gravis: clinical correlations and the direct effects of drugs and myasthenic serum.
    Sanders DB; Kim YI; Howard JF; Johns TR; Muller WH
    Ann N Y Acad Sci; 1981; 377():544-66. PubMed ID: 6280565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.
    Engel AG; Lindstrom JM; Lambert EH; Lennon VA
    Neurology; 1977 Apr; 27(4):307-15. PubMed ID: 557772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization to acetylcholine at motor end plates in normal humans, patients with myasthenia gravis, and experimental models of myasthenia gravis.
    Pagala MK; Namba T; Grob D
    Ann N Y Acad Sci; 1981; 377():567-82. PubMed ID: 6951485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly recognized congenital myasthenic syndrome associated with high conductance and fast closure of the acetylcholine receptor channel.
    Engel AG; Uchitel OD; Walls TJ; Nagel A; Harper CM; Bodensteiner J
    Ann Neurol; 1993 Jul; 34(1):38-47. PubMed ID: 7685992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenic serum selectively blocks acetylcholine receptors with long channel open times at developing rat endplates.
    Schuetze SM; Vicini S; Hall ZW
    Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2533-7. PubMed ID: 2581249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantal components of end-plate potentials in the myasthenic syndrome.
    Lambert EH; Elmqvist D
    Ann N Y Acad Sci; 1971 Sep; 183():183-99. PubMed ID: 4330759
    [No Abstract]   [Full Text] [Related]  

  • 15. Myasthenia gravis as a receptor disorder.
    Drachman DB; Kao I; Pestronk A; Toyka KV
    Ann N Y Acad Sci; 1976; 274():226-34. PubMed ID: 786108
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental autoimmune myasthenia gravis: the rabbit as an animal model.
    Eldefrawi ME
    Fed Proc; 1978 Dec; 37(14):2823-7. PubMed ID: 720635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuromuscular junction: recent developments.
    Bowman WC
    Eur J Anaesthesiol; 1985 Mar; 2(1):59-93. PubMed ID: 2410263
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental autoimmune myasthenia gravis and cholinergic ionophore: an electrophysiologic study.
    Takamori M; Mori M; Kasai M
    Neurology; 1979 Jul; 29(7):945-50. PubMed ID: 572943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of acetylcholine receptors (AChR) in normal and myasthenic human muscle.
    Lecky BR; Morgan-Hughes JA
    Ann N Y Acad Sci; 1981; 377():61-76. PubMed ID: 6951488
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional inhibition of acetylcholine receptors by antibodies in myasthenic sera.
    Hall ZW; Pizzighella S; Gu Y; Vicini S; Schuetze SM
    Ann N Y Acad Sci; 1987; 505():272-85. PubMed ID: 2446552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.